Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
X4 lays
X4 lays off 30% of staff, halts preclinical R&D to focus on Xolremdi rollout
Lipella Pharmaceuticals Granted FDA
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Rani Therapeutics Announces Preclinical
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
FDA grants
FDA grants Orphan Drug Designation to Ariceum cancer therapy
Mozart Therapeutics Presents Compelling
Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn's and Colitis Congress®
Astellas seeks conditional approval for GA treatment in Japan
Astellas seeks conditional approval for GA treatment in Japan
Thermo Fisher
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
IO Biotech Announces Publication
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
FDA Approves Third Biosimilar of Actemra
FDA Approves Third Biosimilar of Actemra
J&J for Cancer Treatment Costs
US Could Seek More Than $1B From J&J for Cancer Treatment Costs
PVRI Congress
Gossamer Bio showcases seralutinib seralutinib Clinical and Preclinical studies at PVRI Congress
Rentschler closes UK
Rentschler closes UK cell and gene therapy facility and does a pivot to biologics
59
60
61
62
63
64
65
66
67
